Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Operating Expenses | 2,673 | 1,334 | 816 | 0 |
| Operating Income | -2,673 | -1,334 | -816 | N/A |
| Other Income | 4 | 0 | 0 | 0 |
| Pre-tax Income | -2,669 | -1,334 | -816 | 0 |
| Net Income Continuous | -2,669 | -1,334 | -816 | N/A |
| Net Income | $-2,669 | $-1,334 | $-816 | $N/A |
| EPS Basic Total Ops | -51.62 | -25.81 | -15.77 | N/A |
| EPS Basic Continuous Ops | -51.62 | -25.81 | -15.68 | N/A |
| EPS Diluted Total Ops | -51.62 | -25.81 | -15.77 | N/A |
| EPS Diluted Continuous Ops | -51.62 | -25.81 | -15.68 | N/A |
| EBITDA(a) | $-2,614 | $-1,309 | $-805 | $N/A |